- Home
- OMH vs INDP Comparison
OMH vs INDP Comparison
Compare OMH & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- INDP
- Stock Information
- Founded
- OMH 2015
- INDP 2000
- Country
- OMH Singapore
- INDP United States
- Employees
- OMH N/A
- INDP N/A
- Industry
- OMH Real Estate
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- INDP Health Care
- Exchange
- OMH Nasdaq
- INDP Nasdaq
- Market Cap
- OMH 9.1M
- INDP 10.2M
- IPO Year
- OMH 2023
- INDP N/A
- Fundamental
- Price
- OMH $0.51
- INDP $0.89
- Analyst Decision
- OMH Strong Buy
- INDP Strong Buy
- Analyst Count
- OMH 1
- INDP 2
- Target Price
- OMH $1.50
- INDP $8.50
- AVG Volume (30 Days)
- OMH 254.3K
- INDP 22.6K
- Earning Date
- OMH 01-10-2025
- INDP 11-12-2024
- Dividend Yield
- OMH N/A
- INDP N/A
- EPS Growth
- OMH N/A
- INDP N/A
- EPS
- OMH N/A
- INDP N/A
- Revenue
- OMH $5,390,607.00
- INDP N/A
- Revenue This Year
- OMH $101.90
- INDP N/A
- Revenue Next Year
- OMH $38.34
- INDP N/A
- P/E Ratio
- OMH N/A
- INDP N/A
- Revenue Growth
- OMH 25.77
- INDP N/A
- 52 Week Low
- OMH $0.32
- INDP $0.81
- 52 Week High
- OMH $6.00
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- OMH 69.54
- INDP 38.00
- Support Level
- OMH $0.37
- INDP $0.81
- Resistance Level
- OMH $0.43
- INDP $0.94
- Average True Range (ATR)
- OMH 0.03
- INDP 0.07
- MACD
- OMH 0.01
- INDP -0.00
- Stochastic Oscillator
- OMH 100.00
- INDP 20.36
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.